ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Latanoprost- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-11M657
Home | Market Reports | Health| Pharmacy
Global Latanoprost Market Insights and Forecast to 2028
BUY CHAPTERS

Latanoprost- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-11M657
Report
August 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Mylan NV
Novartis
Apotex
TEVA
Taj Pharma
CR Zizhu

Latanoprost- Market Size

The global market for Latanoprost was estimated to be worth US$ 1435 million in 2024 and is forecast to a readjusted size of US$ 1667 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.

Latanoprost- Market

Latanoprost- Market

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
This report aims to provide a comprehensive presentation of the global market for Latanoprost, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Latanoprost by region & country, by Type, and by Application.
The Latanoprost market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latanoprost.
Market Segmentation

Scope of Latanoprost- Market Report

Report Metric Details
Report Name Latanoprost- Market
Forecasted market size in 2031 US$ 1667 million
CAGR 2.2%
Forecasted years 2025 - 2031
Segment by Type
  • Brand Drug
  • Generic Drug
Segment by Application
  • Open-angle Glaucoma
  • Close-angle Glaucoma
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Mylan, Novartis, Apotex, Teva, Taj Pharma, CR Zizhu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Latanoprost in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Latanoprost- Market size in 2031?

Ans: The Latanoprost- Market size in 2031 will be US$ 1667 million.

What is the Pfizer, Mylan, Novartis share in Latanoprost- Market?

Ans: Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share.

What is the Latanoprost- Market share by region?

Ans: North America is the major region of the global market, which takes about 35% market share.

Who are the main players in the Latanoprost- Market report?

Ans: The main players in the Latanoprost- Market are Pfizer, Mylan, Novartis, Apotex, Teva, Taj Pharma, CR Zizhu

What are the Application segmentation covered in the Latanoprost- Market report?

Ans: The Applications covered in the Latanoprost- Market report are Open-angle Glaucoma, Close-angle Glaucoma

What are the Type segmentation covered in the Latanoprost- Market report?

Ans: The Types covered in the Latanoprost- Market report are Brand Drug, Generic Drug

1 Market Overview
1.1 Latanoprost Product Introduction
1.2 Global Latanoprost Market Size Forecast
1.2.1 Global Latanoprost Sales Value (2020-2031)
1.2.2 Global Latanoprost Sales Volume (2020-2031)
1.2.3 Global Latanoprost Sales Price (2020-2031)
1.3 Latanoprost Market Trends & Drivers
1.3.1 Latanoprost Industry Trends
1.3.2 Latanoprost Market Drivers & Opportunity
1.3.3 Latanoprost Market Challenges
1.3.4 Latanoprost Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Latanoprost Players Revenue Ranking (2024)
2.2 Global Latanoprost Revenue by Company (2020-2025)
2.3 Global Latanoprost Players Sales Volume Ranking (2024)
2.4 Global Latanoprost Sales Volume by Company Players (2020-2025)
2.5 Global Latanoprost Average Price by Company (2020-2025)
2.6 Key Manufacturers Latanoprost Manufacturing Base and Headquarters
2.7 Key Manufacturers Latanoprost Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Latanoprost
2.9 Latanoprost Market Competitive Analysis
2.9.1 Latanoprost Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Latanoprost Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latanoprost as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Brand Drug
3.1.2 Generic Drug
3.2 Global Latanoprost Sales Value by Type
3.2.1 Global Latanoprost Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Latanoprost Sales Value, by Type (2020-2031)
3.2.3 Global Latanoprost Sales Value, by Type (%) (2020-2031)
3.3 Global Latanoprost Sales Volume by Type
3.3.1 Global Latanoprost Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Latanoprost Sales Volume, by Type (2020-2031)
3.3.3 Global Latanoprost Sales Volume, by Type (%) (2020-2031)
3.4 Global Latanoprost Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Open-angle Glaucoma
4.1.2 Close-angle Glaucoma
4.2 Global Latanoprost Sales Value by Application
4.2.1 Global Latanoprost Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Latanoprost Sales Value, by Application (2020-2031)
4.2.3 Global Latanoprost Sales Value, by Application (%) (2020-2031)
4.3 Global Latanoprost Sales Volume by Application
4.3.1 Global Latanoprost Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Latanoprost Sales Volume, by Application (2020-2031)
4.3.3 Global Latanoprost Sales Volume, by Application (%) (2020-2031)
4.4 Global Latanoprost Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Latanoprost Sales Value by Region
5.1.1 Global Latanoprost Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Latanoprost Sales Value by Region (2020-2025)
5.1.3 Global Latanoprost Sales Value by Region (2026-2031)
5.1.4 Global Latanoprost Sales Value by Region (%), (2020-2031)
5.2 Global Latanoprost Sales Volume by Region
5.2.1 Global Latanoprost Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Latanoprost Sales Volume by Region (2020-2025)
5.2.3 Global Latanoprost Sales Volume by Region (2026-2031)
5.2.4 Global Latanoprost Sales Volume by Region (%), (2020-2031)
5.3 Global Latanoprost Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Latanoprost Sales Value, 2020-2031
5.4.2 North America Latanoprost Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Latanoprost Sales Value, 2020-2031
5.5.2 Europe Latanoprost Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Latanoprost Sales Value, 2020-2031
5.6.2 Asia Pacific Latanoprost Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Latanoprost Sales Value, 2020-2031
5.7.2 South America Latanoprost Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Latanoprost Sales Value, 2020-2031
5.8.2 Middle East & Africa Latanoprost Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Latanoprost Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Latanoprost Sales Value
6.2.1 Key Countries/Regions Latanoprost Sales Value, 2020-2031
6.2.2 Key Countries/Regions Latanoprost Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Latanoprost Sales Value, 2020-2031
6.3.2 United States Latanoprost Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Latanoprost Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Latanoprost Sales Value, 2020-2031
6.4.2 Europe Latanoprost Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Latanoprost Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Latanoprost Sales Value, 2020-2031
6.5.2 China Latanoprost Sales Value by Type (%), 2024 VS 2031
6.5.3 China Latanoprost Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Latanoprost Sales Value, 2020-2031
6.6.2 Japan Latanoprost Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Latanoprost Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Latanoprost Sales Value, 2020-2031
6.7.2 South Korea Latanoprost Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Latanoprost Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Latanoprost Sales Value, 2020-2031
6.8.2 Southeast Asia Latanoprost Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Latanoprost Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Latanoprost Sales Value, 2020-2031
6.9.2 India Latanoprost Sales Value by Type (%), 2024 VS 2031
6.9.3 India Latanoprost Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Pfizer Latanoprost Product Offerings
7.1.5 Pfizer Recent Development
7.2 Mylan
7.2.1 Mylan Company Information
7.2.2 Mylan Introduction and Business Overview
7.2.3 Mylan Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mylan Latanoprost Product Offerings
7.2.5 Mylan Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Introduction and Business Overview
7.3.3 Novartis Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Novartis Latanoprost Product Offerings
7.3.5 Novartis Recent Development
7.4 Apotex
7.4.1 Apotex Company Information
7.4.2 Apotex Introduction and Business Overview
7.4.3 Apotex Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Apotex Latanoprost Product Offerings
7.4.5 Apotex Recent Development
7.5 Teva
7.5.1 Teva Company Information
7.5.2 Teva Introduction and Business Overview
7.5.3 Teva Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Teva Latanoprost Product Offerings
7.5.5 Teva Recent Development
7.6 Taj Pharma
7.6.1 Taj Pharma Company Information
7.6.2 Taj Pharma Introduction and Business Overview
7.6.3 Taj Pharma Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Taj Pharma Latanoprost Product Offerings
7.6.5 Taj Pharma Recent Development
7.7 CR Zizhu
7.7.1 CR Zizhu Company Information
7.7.2 CR Zizhu Introduction and Business Overview
7.7.3 CR Zizhu Latanoprost Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 CR Zizhu Latanoprost Product Offerings
7.7.5 CR Zizhu Recent Development
8 Industry Chain Analysis
8.1 Latanoprost Industrial Chain
8.2 Latanoprost Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Latanoprost Sales Model
8.5.2 Sales Channel
8.5.3 Latanoprost Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Mylan NV
Novartis
Apotex
TEVA
Taj Pharma
CR Zizhu
List of Tables
 Table 1. Latanoprost Market Trends
 Table 2. Latanoprost Market Drivers & Opportunity
 Table 3. Latanoprost Market Challenges
 Table 4. Latanoprost Market Restraints
 Table 5. Global Latanoprost Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Latanoprost Revenue Market Share by Company (2020-2025)
 Table 7. Global Latanoprost Sales Volume by Company (2020-2025) & (M Unit)
 Table 8. Global Latanoprost Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Latanoprost Price by Company (2020-2025) & (USD/Unit)
 Table 10. Key Manufacturers Latanoprost Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Latanoprost Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Latanoprost
 Table 13. Global Latanoprost Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latanoprost as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Latanoprost Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Latanoprost Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Latanoprost Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Latanoprost Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Latanoprost Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Latanoprost Sales Volume by Type: 2020 VS 2024 VS 2031 (M Unit)
 Table 22. Global Latanoprost Sales Volume by Type (2020-2025) & (M Unit)
 Table 23. Global Latanoprost Sales Volume by Type (2026-2031) & (M Unit)
 Table 24. Global Latanoprost Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Latanoprost Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Latanoprost Price by Type (2020-2025) & (USD/Unit)
 Table 27. Global Latanoprost Price by Type (2026-2031) & (USD/Unit)
 Table 28. Global Latanoprost Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Latanoprost Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Latanoprost Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Latanoprost Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Latanoprost Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Latanoprost Sales Volume by Application: 2020 VS 2024 VS 2031 (M Unit)
 Table 34. Global Latanoprost Sales Volume by Application (2020-2025) & (M Unit)
 Table 35. Global Latanoprost Sales Volume by Application (2026-2031) & (M Unit)
 Table 36. Global Latanoprost Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Latanoprost Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Latanoprost Price by Application (2020-2025) & (USD/Unit)
 Table 39. Global Latanoprost Price by Application (2026-2031) & (USD/Unit)
 Table 40. Global Latanoprost Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Latanoprost Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Latanoprost Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Latanoprost Sales Value by Region (2020-2025) & (%)
 Table 44. Global Latanoprost Sales Value by Region (2026-2031) & (%)
 Table 45. Global Latanoprost Sales Volume by Region (M Unit): 2020 VS 2024 VS 2031
 Table 46. Global Latanoprost Sales Volume by Region (2020-2025) & (M Unit)
 Table 47. Global Latanoprost Sales Volume by Region (2026-2031) & (M Unit)
 Table 48. Global Latanoprost Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Latanoprost Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Latanoprost Average Price by Region (2020-2025) & (USD/Unit)
 Table 51. Global Latanoprost Average Price by Region (2026-2031) & (USD/Unit)
 Table 52. Key Countries/Regions Latanoprost Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Latanoprost Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Latanoprost Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Latanoprost Sales Volume, (2020-2025) & (M Unit)
 Table 56. Key Countries/Regions Latanoprost Sales Volume, (2026-2031) & (M Unit)
 Table 57. Pfizer Company Information
 Table 58. Pfizer Introduction and Business Overview
 Table 59. Pfizer Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 60. Pfizer Latanoprost Product Offerings
 Table 61. Pfizer Recent Development
 Table 62. Mylan Company Information
 Table 63. Mylan Introduction and Business Overview
 Table 64. Mylan Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 65. Mylan Latanoprost Product Offerings
 Table 66. Mylan Recent Development
 Table 67. Novartis Company Information
 Table 68. Novartis Introduction and Business Overview
 Table 69. Novartis Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 70. Novartis Latanoprost Product Offerings
 Table 71. Novartis Recent Development
 Table 72. Apotex Company Information
 Table 73. Apotex Introduction and Business Overview
 Table 74. Apotex Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 75. Apotex Latanoprost Product Offerings
 Table 76. Apotex Recent Development
 Table 77. Teva Company Information
 Table 78. Teva Introduction and Business Overview
 Table 79. Teva Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Teva Latanoprost Product Offerings
 Table 81. Teva Recent Development
 Table 82. Taj Pharma Company Information
 Table 83. Taj Pharma Introduction and Business Overview
 Table 84. Taj Pharma Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 85. Taj Pharma Latanoprost Product Offerings
 Table 86. Taj Pharma Recent Development
 Table 87. CR Zizhu Company Information
 Table 88. CR Zizhu Introduction and Business Overview
 Table 89. CR Zizhu Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 90. CR Zizhu Latanoprost Product Offerings
 Table 91. CR Zizhu Recent Development
 Table 92. Key Raw Materials Lists
 Table 93. Raw Materials Key Suppliers Lists
 Table 94. Latanoprost Downstream Customers
 Table 95. Latanoprost Distributors List
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. Latanoprost Product Picture
 Figure 2. Global Latanoprost Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Latanoprost Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Latanoprost Sales Volume (2020-2031) & (M Unit)
 Figure 5. Global Latanoprost Sales Price (2020-2031) & (USD/Unit)
 Figure 6. Latanoprost Report Years Considered
 Figure 7. Global Latanoprost Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Latanoprost Players Sales Volume Ranking (2024) & (M Unit)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Latanoprost Revenue in 2024
 Figure 10. Latanoprost Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Brand Drug Picture
 Figure 12. Generic Drug Picture
 Figure 13. Global Latanoprost Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Latanoprost Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Latanoprost Sales Volume by Type (2020 VS 2024 VS 2031) & (M Unit)
 Figure 16. Global Latanoprost Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Latanoprost Price by Type (2020-2031) & (USD/Unit)
 Figure 18. Product Picture of Open-angle Glaucoma
 Figure 19. Product Picture of Close-angle Glaucoma
 Figure 20. Global Latanoprost Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 21. Global Latanoprost Sales Value Market Share by Application, 2024 & 2031
 Figure 22. Global Latanoprost Sales Volume by Application (2020 VS 2024 VS 2031) & (M Unit)
 Figure 23. Global Latanoprost Sales Volume Market Share by Application, 2024 & 2031
 Figure 24. Global Latanoprost Price by Application (2020-2031) & (USD/Unit)
 Figure 25. North America Latanoprost Sales Value (2020-2031) & (US$ Million)
 Figure 26. North America Latanoprost Sales Value by Country (%), 2024 VS 2031
 Figure 27. Europe Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Europe Latanoprost Sales Value by Country (%), 2024 VS 2031
 Figure 29. Asia Pacific Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 30. Asia Pacific Latanoprost Sales Value by Region (%), 2024 VS 2031
 Figure 31. South America Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 32. South America Latanoprost Sales Value by Country (%), 2024 VS 2031
 Figure 33. Middle East & Africa Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Middle East & Africa Latanoprost Sales Value by Country (%), 2024 VS 2031
 Figure 35. Key Countries/Regions Latanoprost Sales Value (%), (2020-2031)
 Figure 36. Key Countries/Regions Latanoprost Sales Volume (%), (2020-2031)
 Figure 37. United States Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 38. United States Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 39. United States Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 40. Europe Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 41. Europe Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 42. Europe Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 43. China Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 44. China Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 45. China Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 46. Japan Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 47. Japan Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 48. Japan Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 49. South Korea Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 50. South Korea Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 51. South Korea Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 52. Southeast Asia Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 53. Southeast Asia Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 54. Southeast Asia Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 55. India Latanoprost Sales Value, (2020-2031) & (US$ Million)
 Figure 56. India Latanoprost Sales Value by Type (%), 2024 VS 2031
 Figure 57. India Latanoprost Sales Value by Application (%), 2024 VS 2031
 Figure 58. Latanoprost Industrial Chain
 Figure 59. Latanoprost Manufacturing Cost Structure
 Figure 60. Channels of Distribution (Direct Sales, and Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Latanoprost Eye Drop Market Research Report 2024
Global Bimatoprost Eye Drop Market Research Report 2024
Global Conjunctivitis Treatment Eye Drops Market Research Report 2024
Latanoprost API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drops Lubricants Market Insights Forecast to 2030
Global Eyedrops Market Research Report 2025
Global Timolol Market Research Report 2024
Global Eye Drops Artificial Tear Market Research Report 2025
Global Glaucoma Eye Drops Market Research Report 2024
Global Polyethylene Glycol Eye Drops Market Research Report 2024
Global Eye Drops and Lubricants Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Latanoprost and Timolol Ophthalmic Solution Market Research Report 2024
Global Tafluprost Ophthalmic Solution Market Research Report 2024
Global Travoprost Market Research Report 2024
Global Travoprost Reagent Market Research Report 2024
Global Tafluprost Market Insights Forecast to 2030
Global Artificial Tears and Lubricants Market Research Report 2025
Global Brinzolamide Eye Drop Market Research Report 2024
Global Allergy Eye Drop Market Research Report 2025
Difluprednate Ophthalmic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions